Zacks Research Has Strong Forecast for MD FY2026 Earnings

Pediatrix Medical Group, Inc. (NYSE:MD) – Analysts at Zacks Research boosted their FY2026 earnings per share estimates for shares of Pediatrix Medical Group in a research note issued on Monday, March 10th. Zacks Research analyst Z. Masood now anticipates that the company will post earnings of $1.44 per share for the year, up from their prior estimate of $1.43. The consensus estimate for Pediatrix Medical Group’s current full-year earnings is $1.38 per share.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million.

MD has been the topic of several other research reports. Macquarie assumed coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They set an “outperform” rating and a $18.00 target price on the stock. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. UBS Group increased their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a report on Friday, February 21st. Truist Financial increased their price target on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a report on Friday, February 21st. Finally, Mizuho increased their price target on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a report on Tuesday, November 19th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $17.08.

Pediatrix Medical Group Trading Down 0.0 %

NYSE MD opened at $13.71 on Thursday. Pediatrix Medical Group has a 12 month low of $6.62 and a 12 month high of $17.67. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The business’s 50-day moving average price is $14.15 and its two-hundred day moving average price is $13.38. The firm has a market capitalization of $1.18 billion, a PE ratio of -11.42, a price-to-earnings-growth ratio of 1.74 and a beta of 1.48.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Nomura Asset Management Co. Ltd. increased its holdings in shares of Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock worth $33,000 after buying an additional 1,220 shares during the period. Quest Partners LLC increased its holdings in shares of Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after buying an additional 622 shares during the period. Parkside Financial Bank & Trust increased its holdings in Pediatrix Medical Group by 36.1% during the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after purchasing an additional 1,040 shares during the period. Quarry LP increased its holdings in Pediatrix Medical Group by 54.1% during the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after purchasing an additional 1,662 shares during the period. Finally, AlphaQuest LLC increased its holdings in Pediatrix Medical Group by 65.9% during the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock valued at $66,000 after purchasing an additional 2,012 shares during the period. Hedge funds and other institutional investors own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.